This session will open with a conversation with Representative Anna Eshoo, followed by a panel discussion on ARPA-H.

The signature achievements of the federal Defense Advanced Research Projects Agency (DARPA) are well known. Among them were early iterations of the internet, wireless communication, speech recognition, and global positioning systems. More than a decade of advocacy for a similar agency targeting high-risk, high-reward innovations in health has borne fruit in the creation of the Advanced Research Projects Agency for Health (ARPA-H) in 2022. What problems should this new entity focus on solving? How should ARPA-H be structured if it is to achieve the same quality of breakthroughs as DARPA? 

Guest

Anna Eshoo

US Representative, California; Chair, US House Energy and Commerce Subcommittee on Health

Moderators

Margaret Anderson

Managing Director, Deloitte

Esther Krofah

Executive Vice President, MI Health, Milken Institute

Speakers

Christopher Austin

CEO and Partner, Flagship Pioneering

Howard Fillit

Co-Founder and Chief Science Officer, Alzheimer's Drug Discovery Foundation

Susan Monarez

Acting Deputy Director, Advanced Research Projects Agency for Health (ARPA-H)

Tara Schwetz

Acting Principal Deputy Director, National Institutes of Health

Michael Stebbins

President, Science Advisors